Latest Insider Transactions at Encompass Health Corp (EHC)
This section provides a real-time view of insider transactions for Encompass Health Corp (EHC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Encompass Health Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Encompass Health Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 16
2025
|
Christopher R Reidy Director |
BUY
Grant, award, or other acquisition
|
Direct |
333
+2.2%
|
$35,298
$106.89 P/Share
|
|
Jul 16
2025
|
Edward M Christie Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
260
+3.75%
|
$27,560
$106.48 P/Share
|
|
Jul 15
2025
|
Christopher R Reidy Director |
BUY
Grant, award, or other acquisition
|
Direct |
17
+0.12%
|
-
|
|
Jul 15
2025
|
Kevin J. O'Connor Director |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.15%
|
-
|
|
Jul 15
2025
|
Nancy M Schlichting Director |
BUY
Grant, award, or other acquisition
|
Direct |
34
+0.16%
|
-
|
|
Jul 15
2025
|
Joan E Herman Director |
BUY
Grant, award, or other acquisition
|
Direct |
74
+0.16%
|
-
|
|
Jul 15
2025
|
Leslye G Katz Director |
BUY
Grant, award, or other acquisition
|
Direct |
74
+0.16%
|
-
|
|
Jul 15
2025
|
Patricia Anne Maryland Director |
BUY
Grant, award, or other acquisition
|
Direct |
24
+0.16%
|
-
|
|
Jul 15
2025
|
Greg D Carmichael Director |
BUY
Grant, award, or other acquisition
|
Direct |
24
+0.13%
|
-
|
|
Jul 15
2025
|
Edward M Christie Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
8
+0.12%
|
-
|
|
Jul 15
2025
|
Terrance Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
24
+0.16%
|
-
|
|
May 20
2025
|
Mark J Tarr President & CEO |
SELL
Open market or private sale
|
Direct |
118,384
-9.17%
|
$14,324,464
$121.24 P/Share
|
|
May 20
2025
|
Mark J Tarr President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
118,384
+8.79%
|
$4,616,976
$39.87 P/Share
|
|
May 14
2025
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Bona fide gift
|
Direct |
3,667
-3.66%
|
-
|
|
May 06
2025
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,279
-26.35%
|
$496,364
$116.61 P/Share
|
|
May 01
2025
|
Joan E Herman Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+2.9%
|
-
|
|
May 01
2025
|
Edward M Christie Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+18.19%
|
-
|
|
May 01
2025
|
Greg D Carmichael Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+7.12%
|
-
|
|
May 01
2025
|
Kevin J. O'Connor Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+12.61%
|
-
|
|
May 01
2025
|
Patricia Anne Maryland Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+8.81%
|
-
|
|
May 01
2025
|
Leslye G Katz Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+2.9%
|
-
|
|
May 01
2025
|
Nancy M Schlichting Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+6.31%
|
-
|
|
May 01
2025
|
Christopher R Reidy Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+8.98%
|
-
|
|
May 01
2025
|
Terrance Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+8.62%
|
-
|
|
Apr 30
2025
|
Patrick William Tuer EVP, Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,984
+23.15%
|
-
|
|
Apr 29
2025
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
10,000
-11.15%
|
$1,140,000
$114.79 P/Share
|
|
Apr 29
2025
|
John Patrick Darby EVP, Gen Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+10.03%
|
$350,000
$35.06 P/Share
|
|
Apr 29
2025
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
43,575
-16.21%
|
$5,011,125
$115.55 P/Share
|
|
Apr 29
2025
|
Douglas E Coltharp EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
43,575
+19.15%
|
$1,307,250
$31.0 P/Share
|
|
Apr 24
2025
|
Edward M Christie Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
268
+5.1%
|
$27,336
$102.56 P/Share
|
|
Apr 22
2025
|
Christopher R Reidy Director |
BUY
Grant, award, or other acquisition
|
Direct |
360
+2.69%
|
$35,280
$98.23 P/Share
|
|
Apr 15
2025
|
Kevin J. O'Connor Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.15%
|
-
|
|
Apr 15
2025
|
Patricia Anne Maryland Director |
BUY
Grant, award, or other acquisition
|
Direct |
23
+0.17%
|
-
|
|
Apr 15
2025
|
Christopher R Reidy Director |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.12%
|
-
|
|
Apr 15
2025
|
Joan E Herman Director |
BUY
Grant, award, or other acquisition
|
Direct |
76
+0.16%
|
-
|
|
Apr 15
2025
|
Greg D Carmichael Director |
BUY
Grant, award, or other acquisition
|
Direct |
23
+0.13%
|
-
|
|
Apr 15
2025
|
Leslye G Katz Director |
BUY
Grant, award, or other acquisition
|
Direct |
76
+0.16%
|
-
|
|
Apr 15
2025
|
Edward M Christie Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
5
+0.11%
|
-
|
|
Apr 15
2025
|
Terrance Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
23
+0.17%
|
-
|
|
Apr 15
2025
|
Nancy M Schlichting Director |
BUY
Grant, award, or other acquisition
|
Direct |
33
+0.17%
|
-
|
|
Feb 28
2025
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
364
-2.19%
|
$36,400
$100.14 P/Share
|
|
Feb 28
2025
|
Mark J Tarr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,187
-0.41%
|
$218,700
$100.14 P/Share
|
|
Feb 28
2025
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
416
-0.52%
|
$41,600
$100.14 P/Share
|
|
Feb 28
2025
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
776
-1.27%
|
$77,600
$100.14 P/Share
|
|
Feb 28
2025
|
Andrew L Price Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
304
-0.44%
|
$30,400
$100.14 P/Share
|
|
Feb 28
2025
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
276
-0.27%
|
$27,600
$100.14 P/Share
|
|
Feb 25
2025
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,079
-1.74%
|
$107,900
$100.63 P/Share
|
|
Feb 25
2025
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
509
-0.63%
|
$50,900
$100.63 P/Share
|
|
Feb 25
2025
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
506
-2.96%
|
$50,600
$100.63 P/Share
|
|
Feb 25
2025
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
384
-0.38%
|
$38,400
$100.63 P/Share
|